Clal Biotechnology Industries (XTAE:CBI) Interest Expense : ₪-3.57 Mil (TTM As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Clal Biotechnology Industries Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Clal Biotechnology Industries's interest expense for the six months ended in Dec. 2024 was ₪ -0.10 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₪-3.57 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Clal Biotechnology Industries's Operating Income for the six months ended in Dec. 2024 was ₪ -3.03 Mil. Clal Biotechnology Industries's Interest Expense for the six months ended in Dec. 2024 was ₪ -0.10 Mil. Clal Biotechnology Industries did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Clal Biotechnology Industries Interest Expense Historical Data

The historical data trend for Clal Biotechnology Industries's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clal Biotechnology Industries Interest Expense Chart

Clal Biotechnology Industries Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-4.26

-1.76

-3.73

-3.54

-3.57

Clal Biotechnology Industries Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Interest Expense	Get a 7-Day Free Trial															0.05	-3.25	-0.30	-3.47	-0.10

Clal Biotechnology Industries Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₪-3.57 Mil.

Clal Biotechnology Industries (XTAE:CBI) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Clal Biotechnology Industries's Interest Expense for the six months ended in Dec. 2024 was ₪-0.10 Mil. Its Operating Income for the six months ended in Dec. 2024 was ₪-3.03 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2024 was ₪1.53 Mil.

Clal Biotechnology Industries's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Clal Biotechnology Industries did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Clal Biotechnology Industries Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clal Biotechnology Industries Ltd (XTAE:CBI) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Azrieli Center, Triangle Building, 45th Floor, Tel Aviv, ISR, 67023

Website

http://www.cbi.co.il

Clal Biotechnology Industries Ltd is a life sciences investment company. The company invests in companies ranging from seed to maturity, both public and private. Its portfolio of investments includes from heavy industry to biotechnology, hi-tech and energy companies.